ABSTRACT
In 2021, pancreatic ductal adenocarcinoma (PDAC) is the 3rd leading cause of cancer deaths in the United States. This is largely due to a lack of symptoms and limited treatment options, which extend survival by only a few weeks. There is thus an urgent need to develop new therapies effective against PDAC. Previously, we have shown that the growth of PDAC cells is suppressed when they are co-implanted with RabMab1, a rabbit monoclonal antibody specific for human alternatively spliced tissue factor (asTF). Here, we report on humanization of RabMab1, evaluation of its binding characteristics, and assessment of its in vivo properties. hRabMab1 binds asTF with a KD in the picomolar range; suppresses the migration of high-grade Pt45.P1 cells in Boyden chamber assays; has a long half-life in circulation (~ 5 weeks); and significantly slows the growth of pre-formed orthotopic Pt45.P1 tumors in athymic nude mice when administered intravenously. Immunohistochemical analysis of tumor tissue demonstrates the suppression of i) PDAC cell proliferation, ii) macrophage infiltration, and iii) neovascularization, whereas RNAseq analysis of tumor tissue reveals the suppression of pathways that promote cell division and focal adhesion. This is the first proof-of-concept study whereby a novel biologic targeting asTF has been investigated as a systemically administered single agent, with encouraging results. Given that hRabMab1 has a favorable PK profile and is able to suppress the growth of human PDAC cells in vivo, it comprises a promising candidate for further clinical development.
ABSTRACT
Royal jelly is the queen-maker for the honey bee Apis mellifera, and has cross-species effects on longevity, fertility, and regeneration in mammals. Despite this knowledge, how royal jelly or its components exert their myriad effects has remained poorly understood. Using mouse embryonic stem cells as a platform, here we report that through its major protein component Royalactin, royal jelly can maintain pluripotency by activating a ground-state pluripotency-like gene network. We further identify Regina, a mammalian structural analog of Royalactin that also induces a naive-like state in mouse embryonic stem cells. This reveals an important innate program for stem cell self-renewal with broad implications in understanding the molecular regulation of stem cell fate across species.
Subject(s)
Fatty Acids/pharmacology , Glycoproteins/pharmacology , Insect Proteins/pharmacology , Mammals/physiology , Mouse Embryonic Stem Cells/drug effects , Pluripotent Stem Cells/drug effects , Animals , Bees/metabolism , Chromatin , Fatty Acids/chemistry , Female , Fertility , Gene Expression Regulation, Developmental/drug effects , Glycoproteins/chemistry , Insect Proteins/chemistry , Lentivirus/genetics , Lentivirus/metabolism , Longevity , Mice , Models, Molecular , Recombinant Proteins , Teratoma/pathology , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolismABSTRACT
Reduced bone morphogenetic protein receptor 2 (BMPR2) expression in patients with pulmonary arterial hypertension (PAH) can impair pulmonary arterial EC (PAEC) function. This can adversely affect EC survival and promote SMC proliferation. We hypothesized that interventions to normalize expression of genes that are targets of BMPR2 signaling could restore PAEC function and prevent or reverse PAH. Here we have characterized, in human PAECs, a BMPR2-mediated transcriptional complex between PPARγ and ß-catenin and shown that disruption of this complex impaired BMP-mediated PAEC survival. Using whole genome-wide ChIP-Chip promoter analysis and gene expression microarrays, we delineated PPARγ/ß-catenin-dependent transcription of target genes including APLN, which encodes apelin. We documented reduced PAEC expression of apelin in PAH patients versus controls. In cell culture experiments, we showed that apelin-deficient PAECs were prone to apoptosis and promoted pulmonary arterial SMC (PASMC) proliferation. Conversely, we established that apelin, like BMPR2 ligands, suppressed proliferation and induced apoptosis of PASMCs. Consistent with these functions, administration of apelin reversed PAH in mice with reduced production of apelin resulting from deletion of PPARγ in ECs. Taken together, our findings suggest that apelin could be effective in treating PAH by rescuing BMPR2 and PAEC dysfunction.
Subject(s)
Bone Morphogenetic Protein Receptors, Type II/metabolism , Cell Survival , Endothelial Cells/physiology , Intercellular Signaling Peptides and Proteins/metabolism , PPAR gamma/metabolism , beta Catenin/metabolism , Adipokines , Animals , Apelin , Apoptosis/physiology , Bone Morphogenetic Protein Receptors, Type II/genetics , Bone Morphogenetic Proteins/metabolism , Cell Proliferation , Cells, Cultured , Endothelial Cells/cytology , Gene Expression , Humans , Intercellular Signaling Peptides and Proteins/genetics , Mice , Microarray Analysis , PPAR gamma/genetics , Pulmonary Artery/cytology , RNA, Small Interfering/metabolism , beta Catenin/geneticsABSTRACT
Long intergenic noncoding RNAs (lincRNAs) regulate chromatin states and epigenetic inheritance. Here, we show that the lincRNA HOTAIR serves as a scaffold for at least two distinct histone modification complexes. A 5' domain of HOTAIR binds polycomb repressive complex 2 (PRC2), whereas a 3' domain of HOTAIR binds the LSD1/CoREST/REST complex. The ability to tether two distinct complexes enables RNA-mediated assembly of PRC2 and LSD1 and coordinates targeting of PRC2 and LSD1 to chromatin for coupled histone H3 lysine 27 methylation and lysine 4 demethylation. Our results suggest that lincRNAs may serve as scaffolds by providing binding surfaces to assemble select histone modification enzymes, thereby specifying the pattern of histone modifications on target genes.
Subject(s)
Chromatin/metabolism , DNA-Binding Proteins/metabolism , Histone Demethylases/metabolism , Histones/metabolism , RNA, Untranslated/metabolism , Repressor Proteins/metabolism , Transcription Factors/metabolism , Binding Sites , Carrier Proteins/metabolism , Cell Line , Cells, Cultured , Chromatin Immunoprecipitation , Co-Repressor Proteins , Enhancer of Zeste Homolog 2 Protein , HeLa Cells , Humans , Methylation , Mutation , Neoplasm Proteins , Nerve Tissue Proteins/metabolism , Nuclear Proteins/metabolism , Nucleic Acid Conformation , Polycomb Repressive Complex 2 , Polycomb-Group Proteins , Promoter Regions, Genetic , Protein Binding , RNA Interference , RNA, Untranslated/chemistry , Transcription, GeneticSubject(s)
Drosophila Proteins/metabolism , Gene Expression Regulation, Neoplastic , Histone Demethylases/metabolism , Histones/metabolism , Nuclear Proteins/metabolism , Oxidoreductases, N-Demethylating/metabolism , Animals , Drosophila , G1 Phase , Humans , Jumonji Domain-Containing Histone Demethylases/metabolism , Methylation , Neoplasms/metabolism , Neoplasms/pathology , Retinoblastoma Binding Proteins/metabolism , Retinoblastoma Protein/metabolism , S PhaseABSTRACT
Trimethylation of histone H3 on Lys 27 (H3K27me3) is key for cell fate regulation. The H3K27me3 demethylase UTX functions in development and tumor suppression with undefined mechanisms. Here, genome-wide chromatin occupancy analysis of UTX and associated histone modifications reveals distinct classes of UTX target genes, including genes encoding Retinoblastoma (RB)-binding proteins. UTX removes H3K27me3 and maintains expression of several RB-binding proteins, enabling cell cycle arrest. Genetic interactions in mammalian cells and Caenorhabditis elegans show that UTX regulates cell fates via RB-dependent pathways. Thus, UTX defines an evolutionarily conserved mechanism to enable coordinate transcription of a RB network in cell fate control.
Subject(s)
Cell Differentiation/physiology , Gene Expression Regulation , Jumonji Domain-Containing Histone Demethylases/metabolism , Retinoblastoma Binding Proteins/metabolism , Animals , Caenorhabditis elegans/metabolism , Cell Line, Tumor , Cell Proliferation , Cells, Cultured , Chromatin/metabolism , Genome/genetics , Humans , Jumonji Domain-Containing Histone Demethylases/genetics , Methylation , Mice , Neoplasms/metabolism , Retinoblastoma Binding Proteins/geneticsABSTRACT
Human skin exhibits exquisite site-specific morphologies and functions. How are these site-specific differences specified during development, maintained in adult homeostasis, and potentially perturbed by disease processes? Here, we review progress in understanding the anatomic patterning of fibroblasts, a major constituent cell type of the dermis and key participant in epithelial-mesenchymal interactions. The gene expression programs of human fibroblasts largely reflect the superimposition of three gene expression profiles that demarcate the fibroblast's position relative to three developmental axes. The HOX family of homeodomain transcription factors is implicated in specifying site-specific transcriptional programs. The use of gene, tiling, and tissue microarrays together gives a comprehensive view of the gene regulation involved in patterning the skin.
Subject(s)
Body Patterning/genetics , Fibroblasts/metabolism , Gene Expression Regulation, Developmental , Skin/anatomy & histology , Skin/embryology , Cell Differentiation/genetics , Epigenesis, Genetic , Homeodomain Proteins/metabolism , Humans , Skin/cytology , Systems Biology , Transcription Factors/metabolismABSTRACT
Reciprocal epithelial-mesenchymal interactions shape site-specific development of skin. Here we show that site-specific HOX expression in fibroblasts is cell-autonomous and epigenetically maintained. The distal-specific gene HOXA13 is continually required to maintain the distal-specific transcriptional program in adult fibroblasts, including expression of WNT5A, a morphogen required for distal development. The ability of distal fibroblasts to induce epidermal keratin 9, a distal-specific gene, is abrogated by depletion of HOXA13, but rescued by addition of WNT5A. Thus, maintenance of appropriate HOX transcriptional program in adult fibroblasts may serve as a source of positional memory to differentially pattern the epithelia during homeostasis and regeneration.
Subject(s)
Epidermis/embryology , Homeodomain Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Wnt Proteins/metabolism , Animals , Body Patterning/physiology , Cell Differentiation/physiology , Epidermis/metabolism , Epigenesis, Genetic , Epithelium/embryology , Epithelium/physiology , Fibroblasts/cytology , Fibroblasts/physiology , Gene Expression Regulation, Developmental , Keratins/metabolism , Mice , Wnt-5a ProteinABSTRACT
The recent discovery of a large number of histone demethylases suggests a central role for these enzymes in regulating histone methylation dynamics. Histone H3K27 trimethylation (H3K27me3) has been linked to polycomb-group-protein-mediated suppression of Hox genes and animal body patterning, X-chromosome inactivation and possibly maintenance of embryonic stem cell (ESC) identity. An imbalance of H3K27 methylation owing to overexpression of the methylase EZH2 has been implicated in metastatic prostate and aggressive breast cancers. Here we show that the JmjC-domain-containing related proteins UTX and JMJD3 catalyse demethylation of H3K27me3/2. UTX is enriched around the transcription start sites of many HOX genes in primary human fibroblasts, in which HOX genes are differentially expressed, but is selectively excluded from the HOX loci in ESCs, in which HOX genes are largely silent. Consistently, RNA interference inhibition of UTX led to increased H3K27me3 levels at some HOX gene promoters. Importantly, morpholino oligonucleotide inhibition of a zebrafish UTX homologue resulted in mis-regulation of hox genes and a striking posterior developmental defect, which was partially rescued by wild-type, but not by catalytically inactive, human UTX. Taken together, these findings identify a small family of H3K27 demethylases with important, evolutionarily conserved roles in H3K27 methylation regulation and in animal anterior-posterior development.
Subject(s)
Body Patterning , Histones/metabolism , Lysine/metabolism , Nuclear Proteins/metabolism , Zebrafish Proteins/metabolism , Zebrafish/embryology , Animals , Cell Line , Embryo, Nonmammalian/embryology , Gene Expression Regulation, Developmental , Genes, Homeobox/genetics , Genome/genetics , Histone Demethylases , Humans , Jumonji Domain-Containing Histone Demethylases , Methylation , Mice , Nuclear Proteins/genetics , Oxidoreductases, N-Demethylating/genetics , Oxidoreductases, N-Demethylating/metabolism , Transcription, Genetic/genetics , Zebrafish/genetics , Zebrafish Proteins/geneticsABSTRACT
Noncoding RNAs (ncRNA) participate in epigenetic regulation but are poorly understood. Here we characterize the transcriptional landscape of the four human HOX loci at five base pair resolution in 11 anatomic sites and identify 231 HOX ncRNAs that extend known transcribed regions by more than 30 kilobases. HOX ncRNAs are spatially expressed along developmental axes and possess unique sequence motifs, and their expression demarcates broad chromosomal domains of differential histone methylation and RNA polymerase accessibility. We identified a 2.2 kilobase ncRNA residing in the HOXC locus, termed HOTAIR, which represses transcription in trans across 40 kilobases of the HOXD locus. HOTAIR interacts with Polycomb Repressive Complex 2 (PRC2) and is required for PRC2 occupancy and histone H3 lysine-27 trimethylation of HOXD locus. Thus, transcription of ncRNA may demarcate chromosomal domains of gene silencing at a distance; these results have broad implications for gene regulation in development and disease states.
Subject(s)
Body Patterning/genetics , Chromatin/genetics , Embryonic Development/genetics , Genes, Homeobox/genetics , RNA Interference/physiology , RNA, Untranslated/genetics , Animals , Base Sequence/genetics , Cells, Cultured , DNA Methylation , Epigenesis, Genetic/genetics , Gene Expression Regulation, Developmental/genetics , Histones/genetics , Humans , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Polycomb-Group Proteins , RNA, Untranslated/chemistry , Regulatory Elements, Transcriptional/genetics , Repressor Proteins/geneticsABSTRACT
Sonic hedgehog (Shh) signaling plays a critical role during development and carcinogenesis. While Gli family members govern the transcriptional output of Shh signaling, little is known how Gli-mediated transcriptional activity is regulated. Here we identify the actin-binding protein Missing in Metastasis (MIM) as a new Shh-responsive gene. Together, Gli1 and MIM recapitulate Shh-mediated epidermal proliferation and invasion in regenerated human skin. MIM is part of a Gli/Suppressor of Fused complex and potentiates Gli-dependent transcription using domains distinct from those used for monomeric actin binding. These data define MIM as both a Shh-responsive gene and a new member of the pathway that modulates Gli responses during growth and tumorigenesis.